Uso della Proteina Inibitore 2 della Dissociazione di RHO GDP come Marcatore Diagnostico e Prognostico delle Malattie Infiammatorie Intestinali, Stronati, Laura, Vitali Roberta, and Cucchiara Salvatore , Number 102017000083055, (2017)

Fecal HMGB1 reveals microscopic inflammation in adult and pediatric patients with inflammatory bowel disease in clinical and endoscopic remission, Palone, Francesca, Vitali Roberta, Cucchiara S., Mennini M., Armuzzi A., Pugliese D., D'incà R., Barberio B., and Stronati L. , Inflammatory Bowel Diseases, Volume 22, Number 12, p.2886-2893, (2016)

NOD2 induces autophagy to control AIEC bacteria infectiveness in intestinal epithelial cells, Negroni, Anna, Colantoni Eleonora, Vitali Roberta, Palone Francesca, Pierdomenico Maria, Costanzo Manuela, Cesi Vincenzo, Cucchiara S., and Stronati L. , Inflamm Res, 2016 Oct, Volume 65, Issue 10, p.803-13, (2016)

NOD2 Is Regulated by MIR-320 in Physiological Conditions but this Control Is Altered in Inflamed Tissues of Patients with Inflammatory Bowel Disease, Pierdomenico, Maria, Cesi Vincenzo, Cucchiara S., Vitali Roberta, Prete E., Costanzo Manuela, Aloi M., Oliva S., and Stronati L. , Inflammatory Bowel Diseases, Volume 22, Number 2, p.315-326, (2016)

Dipotassium glycyrrhizate via HMGB1 or AMPK signaling suppresses oxidative stress during intestinal inflammation, Vitali, Roberta, Palone Francesca, Pierdomenico Maria, Negroni Anna, Cucchiara S., Aloi M., Oliva S., and Stronati L. , Biochemical Pharmacology, Volume 97, Number 3, p.292-299, (2015)

Endoplasmic reticulum stress and unfolded protein response are involved in paediatric inflammatory bowel disease, Negroni, Anna, Prete E., Vitali Roberta, Cesi Vincenzo, Aloi M., Civitelli F., Cucchiara S., and Stronati L. , Digestive and Liver Disease, Volume 46, Number 9, p.788-794, (2014)

Necroptosis is active in children with inflammatory bowel disease and contributes to heighten intestinal inflammation, Pierdomenico, Maria, Negroni Anna, Stronati L., Vitali Roberta, Prete E., Bertin J., Gough P.J., Aloi M., and Cucchiara S. , American Journal of Gastroenterology, Volume 109, Number 2, p.279-287, (2014)

Plasma high mobility group box 1 protein reflects fibrosis in pediatric nonalcoholic fatty liver disease, Alisi, A., Nobili V., Ceccarelli S., Panera N., De Stefanis C., De Vito R., Vitali Roberta, Bedogni G., Balsano C., Cucchiara S., et al. , Expert Review of Molecular Diagnostics, Volume 14, Number 6, p.763-771, (2014)

Role of HMGB1 as a suitable biomarker of subclinical intestinal inflammation and mucosal healing in patients with inflammatory bowel disease, Palone, Francesca, Vitali Roberta, Cucchiara S., Pierdomenico Maria, Negroni Anna, Aloi M., Nuti F., Felice C., Armuzzi A., and Stronati L. , Inflammatory Bowel Diseases, Volume 20, Number 8, p.1448-1457, (2014)

Dipotassium Glycyrrhizate Inhibits HMGB1-Dependent Inflammation and Ameliorates Colitis in Mice, Vitali, Roberta, Palone Francesca, Cucchiara S., Negroni Anna, Cavone L., Costanzo Manuela, Aloi M., Dilillo A., and Stronati L. , PLoS ONE, Volume 8, Number 6, p.e66527, (2013)

Tu1622 Glycyrrhizin Decreases HMGB1 Release and Is Effective for the Treatment of Chemical-Induced Murine Colitis, Vitali, Roberta, Palone Francesca, Negroni Anna, Costanzo Manuela, Dilillo Anna, Aloi Marina, D'Arcangelo Giulia, Cucchiara Salvatore, and Stronati Laura , Gastroenterology, Volume 5, Number 144, p.S–808, (2013)

Characterization of adherent-invasive Escherichia coli isolated from pediatric patients with inflammatory bowel disease, Negroni, Anna, Costanzo Manuela, Vitali Roberta, Superti F., Bertuccini L., Tinari A., Minelli F., Di Nardo G., Nuti F., Pierdomenico Maria, et al. , Inflammatory Bowel Diseases, Volume 18, Number 5, p.913-924, (2012)

Fecal HMGB1 is a novel marker of intestinal mucosal inflammation in pediatric inflammatory bowel disease, Vitali, Roberta, Stronati L., Negroni Anna, Di Nardo G., Pierdomenico Maria, Del Giudice E., Rossi P., and Cucchiara S. , American Journal of Gastroenterology, Volume 106, Number 11, p.2029-2040, (2011)

New insights into the pathogenesis of inflammatory bowel disease: Transcription factors analysis in bioptic tissues from pediatric patients, Pierdomenico, Maria, Stronati L., Costanzo Manuela, Vitali Roberta, Di Nardo G., Nuti F., Oliva S., Cucchiara S., and Negroni Anna , Journal of Pediatric Gastroenterology and Nutrition, Volume 52, Number 3, p.271-279, (2011)

The nuclear protein HMGB1 is increased in the stools of IBD patients and appears to be a novel marker of intestinal inflammation, Stronati, Laura, Vitali Roberta, Negroni Anna, Di Nardo Giovanni, Del Giudice Emanuela, Costanzo Manuela, Pierdomenico Maria, Rossi Paolo, and Cucchiara Salvatore , Gastroenterology, Volume 5, Number 140, p.S–491, (2011)

Alternative splicing of the cyclin D1 proto-oncogene is regulated by the RNA-binding protein Sam68, Paronetto, M.P., Cappellari M., Busà R., Pedrotti S., Vitali Roberta, Comstock C., Hyslop T., Knudsen K.E., and Sette C. , Cancer Research, Volume 70, Number 1, p.229-239, (2010)

Authors' reply to: Inhibition of immune responses by Dasatinib may account for its different effects on neuroblastoma between in vitro and in vivo, Vitali, Roberta, and Raschellà Giuseppe , International Journal of Cancer, Volume 127, Number 5, p.1250, (2010)

CEACAM6 (CELL ADHESION MOLECULE 6 RELATED TO CARCINOEMBRYONIC ANTIGEN): A POSSIBLE ROLE IN PEDIATRIC CROHN'S DISEASE?, Costanzo, Manuela, Pierdomenico Maria, Stronati L, Negroni Anna, Vitali Roberta, Di Camillo C, Del Giudice E, Cavallari N, and Cucchiara S , JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION, Volume 50, p.E99–E100, (2010)

T1804 CEACAM6: A Possible Role in Pediatric Crohn's Disease?, Costanzo, Manuela, Pierdomenico Maria, Stronati Laura, Negroni Anna, Vitali Roberta, Di Nardo Giovanni, Oliva Salvatore, Aloi Marina, and Cucchiara Salvatore , Gastroenterology, Volume 5, Number 138, p.S–582, (2010)

Activity of tyrosine kinase inhibitor Dasatinib in neuroblastoma cells in vitro and in orthotopic mouse model., Vitali, Roberta, Mancini Camillo, Cesi Vincenzo, Tanno Barbara, Piscitelli Marta, Mancuso Mariateresa, Sesti Fabiola, Pasquali Emanuela, Calabretta Bruno, Dominici Carlo, et al. , Int J Cancer, 2009 Dec 01, Volume 125, Issue 11, Number 11, p.2547-55, (2009)

Activation of p53-dependent responses in tumor cells treated with a PARC-interacting peptide, Vitali, Roberta, Cesi Vincenzo, Tanno Barbara, Ferrari-Amorotti G., Dominici C., Calabretta B., and Raschellà Giuseppe , Biochemical and Biophysical Research Communications, Volume 368, Number 2, p.350-356, (2008)

Clinical significance of CXC chemokine receptor-4 and c-Met in childhood rhabdomyosarcoma, Diomedi-Camassei, F., McDowell H.P., De loris M.A., Uccini S., Altavista P., Raschellà G., Vitali Roberta, Mannarino O., De Sio L., Cozzi D.A., et al. , Clinical Cancer Research, Volume 14, Number 13, p.4119-4127, (2008)

Slug (SNAI2) down-regulation by interference facilitates apoptosis and inhibits invasive growth in neuroblastoma preclinical models, Vitali, Roberta, Mancini C., Cesi Vincenzo, Tanno Barbara, Mancuso Mariateresa, Bossi G., Zhang Y., Martinez R.V., Calabretta B., Dominici C., et al. , Clinical Cancer Research, Volume 14, Number 14, p.4622-4630, (2008)

Bim-dependent apoptosis follows IGFBP-5 down-regulation in neuroblastoma cells., Tanno, Barbara, Vitali Roberta, De Arcangelis Davide, Mancini Camillo, Eleuteri Patrizia, Dominici Carlo, and Raschellà Giuseppe , Biochem Biophys Res Commun, 2006 Dec 15, Volume 351, Issue 2, Number 2, p.547-52, (2006)

Down-regulation of insulin-like growth factor I receptor activity by NVP-AEW541 has an antitumor effect on neuroblastoma cells in vitro and in vivo, Tanno, Barbara, Mancini C., Vitali Roberta, Mancuso Mariateresa, McDowell H.P., Dominici C., and Raschellà G. , Clinical Cancer Research, Volume 12, Number 22, p.6772-6780, (2006)